Global Drug Spending To Climb Amid Market Shifts, Report Says

Law360, New York (July 12, 2012, 9:25 PM EDT) -- Global spending growth on pharmaceuticals will rebound over the next several years, despite relatively slow growth in developed countries like the United States and a continuing wave of patent expirations, predicted a report released Thursday.

The IMS Institute for Healthcare Informatics, which tracks pharmaceutical spending, estimated that drug spending growth will more than double between now and 2016, from $30 billion a year to $70 billion a year. Drug spending worldwide could hit $1.2 trillion that year, the report said.

That growth will be fueled by...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.